PD-1 antibody Clinical Trials
12 recruitingDrug
Phase 210Phase 33Phase 11
Showing 1–12 of 12 trials
Recruiting
Phase 2
PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL
Natural Killer/T-cell Lymphoma
Ruijin Hospital47 enrolled1 locationNCT07380984
Recruiting
Phase 2
Vebrekotuzumab ± Anti-PD-1 in Pretreated Advanced ESCC
Esophageal Squamous Cell Carcinoma
Fudan University52 enrolled1 locationNCT07403136
Recruiting
Phase 2Phase 3
PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer
Recurrent Cervical CancerMetastatic Cervical CancerPersistent Cervical Cancer
N.N. Alexandrov National Cancer Centre120 enrolled1 locationNCT07472153
Recruiting
Phase 3
Node-sparing Short-Course Radiation Combined With CAPOX and Tislelizumab for MSS Rectal Cancer
Rectal Cancer
Sir Run Run Shaw Hospital170 enrolled1 locationNCT06507371
Recruiting
Phase 1Phase 2
EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma
Nasopharyngeal Cancinoma (NPC)Metastatic Nasopharyngeal CarcinomaRecurrent Nasopharynx Carcinoma
Sun Yat-Sen University Cancer Center148 enrolled1 locationNCT06802835
Recruiting
Phase 2
Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer
Locally Recurrent Rectal Cancer
Fudan University221 enrolled1 locationNCT06928584
Recruiting
Phase 2
MR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal Cancer
Locally Advanced Rectal Cancer
Fudan University46 enrolled1 locationNCT06840665
Recruiting
Phase 2
The Combination of Immunotherapy and Neoadjuvant Short-course Radiotherapy in Early Rectal Cancer
Early Low Rectal Cancer
Fudan University34 enrolled1 locationNCT05555888
Recruiting
Phase 2
Nodes-sparing Short-course Radiation Combined With CAPOX and Tislelizumab for MSS Middle and Low Rectal Cancer
Sir Run Run Shaw Hospital32 enrolled1 locationNCT05972655
Recruiting
Phase 2
The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer
Recurrent Rectal Cancer
Fudan University93 enrolled1 locationNCT05628038
Recruiting
Phase 2
Short-course Radiotherapy Combined With CapeOx and PD-1 Inhibitor After Local Excision for High-risk Early Rectal Cancer (TORCH-LE)
Rectal Cancer
Fudan University60 enrolled1 locationNCT06455124
Recruiting
Phase 3
Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
Sun Yat-sen University556 enrolled1 locationNCT05342792